A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.
Publication
, Journal Article
Tcheng, JE
Published in: Am Heart J
October 1999
Duke Scholars
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
October 1999
Volume
138
Issue
4 Pt 2
Start / End Page
261 / 262
Location
United States
Related Subject Headings
- Tyrosine
- Tirofiban
- Safety
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Peptides
- Myocardial Ischemia
- Myocardial Infarction
- Immunoglobulin Fab Fragments
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Tcheng, J. E. (1999). A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. Am Heart J, 138(4 Pt 2), 261–262. https://doi.org/10.1053/hj.1999.v138.a100464
Tcheng, J. E. “A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.” Am Heart J 138, no. 4 Pt 2 (October 1999): 261–62. https://doi.org/10.1053/hj.1999.v138.a100464.
Tcheng JE. A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. Am Heart J. 1999 Oct;138(4 Pt 2):261–2.
Tcheng, J. E. “A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.” Am Heart J, vol. 138, no. 4 Pt 2, Oct. 1999, pp. 261–62. Pubmed, doi:10.1053/hj.1999.v138.a100464.
Tcheng JE. A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. Am Heart J. 1999 Oct;138(4 Pt 2):261–262.
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
October 1999
Volume
138
Issue
4 Pt 2
Start / End Page
261 / 262
Location
United States
Related Subject Headings
- Tyrosine
- Tirofiban
- Safety
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Peptides
- Myocardial Ischemia
- Myocardial Infarction
- Immunoglobulin Fab Fragments
- Humans